Results 261 to 270 of about 82,320 (302)

Live Attenuated Influenza Vaccine - A review

Journal of preventive medicine and hygiene, 2011
Owing to the variability of influenza viruses, vaccine composition needs to be up-dated annually. As many variables can influence their efficacy, vaccines are still considered ?sub-optimal?. Many studies have been carried out in recent years to improve vaccines.
GASPARINI, ROBERTO, AMICIZIA, DANIELA, LAI, PIERO LUIGI, PANATTO, DONATELLA   +3 more
openaire   +3 more sources

Live Attenuated Influenza Vaccine

2014
Cold-adapted Ann Arbor based live attenuated influenza vaccine (LAIV) has been available in the USA since 2003. The vaccine is efficacious against influenza infection. Features of LAIV include: easy administration suitable for mass immunization, cross-reactivity to drifted strains for broader coverage, and establishment of herd immunity for control of ...
Hong, Jin, Kanta, Subbarao
openaire   +2 more sources

Live Attenuated Vaccine Vectors

International Journal of Technology Assessment in Health Care, 1994
AbstractSeveral different live attenuated vaccine vectors currently are under development. These vaccines are composed of living viruses or bacteria that are innocuous to the host but can replicate in host tissues and induce immune responses. The genes encoding foreign antigens can be inserted into these vectors to produce multivalent vaccines that ...
openaire   +2 more sources

An attenuated vaccine for AIDS?

The Lancet, 1995
One of the few bright prospects in AIDS research is the findings from a study of an attenuated SIV vaccine in monkeys. The vaccine consists of SIV with the nef region deleted (SIVmac239). All 6 monkeys vaccinated with the nef-deleted virus were still healthy and alive 5 years after vaccination while 11 of the 12 rhesus monkeys administered the virulent
openaire   +2 more sources

Vaccination with Live Attenuated Measles Virus

Archives of Pediatrics & Adolescent Medicine, 1962
Introduction Isolation of the virus of measles in human tissue culture and its subsequent adaptation to growth in embryonated eggs and chick embryo cell culture by Enders and his colleagues 1-3 has led to the rapid development in the United States of vaccines suitable for use in the immunoprophylaxis of this disease.
R B, HORNICK, A E, SCHLUEDERBERG, F R, McCRUMB   +2 more
openaire   +2 more sources

Live-attenuated chikungunya virus vaccine

Cell
Although Chikungunya fever does not a have a high fatality rate (
Lisa F P, Ng, Laurent, Rénia
openaire   +2 more sources

Generation of a live attenuated influenza A vaccine by proteolysis targeting

Nature Biotechnology, 2022
Longlong Si, Haiqing Bai, Tang Feng
exaly  

Attenuated Smallpox Vaccine

New England Journal of Medicine, 1970
S, Krugman, S L, Katz
  +6 more sources

Attenuated HIV Vaccine: Caveats

Science, 1996
R M, Ruprecht, T W, Baba, V, Liska
openaire   +2 more sources

Attenuated vaccines for animal diseases

Vaccine, 2008
Ulrike, Seitzer, Jabbar, Ahmed
openaire   +2 more sources